Experienced in Intertrigo

Dr. Scott Dinehart

Dermatology
Office
9601 Baptist Health Dr Ste 860, 
Little Rock, AR 
Experienced in Intertrigo
Office
9601 Baptist Health Dr Ste 860, 
Little Rock, AR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Scott Dinehart is a Dermatologist in Little Rock, Arkansas. Dr. Dinehart is rated as an Experienced provider by MediFind in the treatment of Intertrigo. His top areas of expertise are Bowen's Disease, Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, and Actinic Keratosis.

His clinical research consists of co-authoring 14 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in AR
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Arkansas Health and Wellness
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
HMO Partners
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
QualChoice
  • MEDICARE MAPD
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Office
9601 Baptist Health Dr Ste 860, Little Rock, AR 72205
Call: 501-975-7455
Other Locations
Office
15506 Highway 5 Ste A, Cabot, AR 72023
Call: 501-941-3101

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Phase Ib, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study of the Clinical Effect, Safety and Tolerability of a Single Intravenous Infusion of GSK1070806 in Moderate to Severe Atopic Dermatitis Patients
A Phase Ib, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study of the Clinical Effect, Safety and Tolerability of a Single Intravenous Infusion of GSK1070806 in Moderate to Severe Atopic Dermatitis Patients
Enrollment Status: Completed
Publish Date: August 28, 2025
Intervention Type: Drug
Study Drug: GSK1070806
Study Phase: Phase 1
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Patients With Psoriasis
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Patients With Psoriasis
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: LY3471851
Study Phase: Phase 1
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Patients With Atopic Dermatitis
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Patients With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: NKTR-358
Study Phase: Phase 1
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drug: Lebrikizumab
Study Phase: Phase 3
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 24, 2023
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Crossover Study to Evaluate the Efficacy and Safety of LY3454738 in Adults With Chronic Spontaneous Urticaria Inadequately Controlled With H1-Antihistamines
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Crossover Study to Evaluate the Efficacy and Safety of LY3454738 in Adults With Chronic Spontaneous Urticaria Inadequately Controlled With H1-Antihistamines
Enrollment Status: Terminated
Publish Date: March 11, 2022
Intervention Type: Drug
Study Drug: LY3454738
Study Phase: Phase 2
Phase 1, Multicenter, Randomized, Placebo-Controlled, Triple-Blind, Single-Ascending Dose and Repeat-Dose Trial in Healthy Participants and Participants With Atopic Dermatitis
Phase 1, Multicenter, Randomized, Placebo-Controlled, Triple-Blind, Single-Ascending Dose and Repeat-Dose Trial in Healthy Participants and Participants With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 06, 2021
Intervention Type: Drug
Study Drug: LY3454738
Study Phase: Phase 1
View 7 Less Clinical Trials

13 Total Publications

A review of the safety, efficacy, and administration of hedgehog inhibitors for the treatment of advanced basal cell carcinoma: an expert consensus panel.
A review of the safety, efficacy, and administration of hedgehog inhibitors for the treatment of advanced basal cell carcinoma: an expert consensus panel.
Journal: Dermatology online journal
Published: July 24, 2025
View All 13 Publications
Similar Doctors
Distinguished in Intertrigo
Dr. Jay Flaming
Dermatology
Distinguished in Intertrigo
Dr. Jay Flaming
Dermatology

Corning Clinical Laboratories

500 S University Ave Ste 506, 
Little Rock, AR 
 (1.8 miles away)
501-664-4257
Languages Spoken:
English
See accepted insurances

Jay Flaming is a Dermatologist in Little Rock, Arkansas. Dr. Flaming is rated as a Distinguished provider by MediFind in the treatment of Intertrigo. His top areas of expertise are Epidermodysplasia Verruciformis, Autoerythrocyte Sensitivity, Purpura, and Gardner-Diamond Syndrome.

Advanced in Intertrigo
Dr. Matthew Kagy
Dermatology
Advanced in Intertrigo
Dr. Matthew Kagy
Dermatology

Office

500 S University Ave Ste 301, 
Little Rock, AR 
 (1.8 miles away)
501-664-4161
Languages Spoken:
English
See accepted insurances

Matthew Kagy is a Dermatologist in Little Rock, Arkansas. Dr. Kagy is rated as an Advanced provider by MediFind in the treatment of Intertrigo. His top areas of expertise are Seborrheic Keratosis, Warts, Actinic Keratosis, and Intertrigo.

Advanced in Intertrigo
Dr. Daniel Smith
Dermatology
Advanced in Intertrigo
Dr. Daniel Smith
Dermatology

Arkansas Dermatopathology PLLC

9601 Baptist Health Dr Ste 690, 
Little Rock, AR 
 (1.8 miles away)
501-227-8422
Languages Spoken:
English
See accepted insurances

Daniel Smith is a Dermatologist in Little Rock, Arkansas. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Intertrigo. His top areas of expertise are Seborrheic Keratosis, Liver Spots, Universal Acquired Melanosis, and Warts.

VIEW MORE INTERTRIGO DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dinehart's expertise for a condition
ConditionClose
    • Distinguished
    • Basal Cell Skin Cancer
      Dr. Dinehart is
      Distinguished
      . Learn about Basal Cell Skin Cancer.
      See more Basal Cell Skin Cancer experts
    • Bowen's Disease
      Dr. Dinehart is
      Distinguished
      . Learn about Bowen's Disease.
      See more Bowen's Disease experts
    • Advanced
    • Actinic Keratosis
      Dr. Dinehart is
      Advanced
      . Learn about Actinic Keratosis.
      See more Actinic Keratosis experts
    • Extramammary Paget Disease
      Dr. Dinehart is
      Advanced
      . Learn about Extramammary Paget Disease.
      See more Extramammary Paget Disease experts
    • Head and Neck Squamous Cell Carcinoma (HNSCC)
      Dr. Dinehart is
      Advanced
      . Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
      See more Head and Neck Squamous Cell Carcinoma (HNSCC) experts
    • Squamous Cell Skin Carcinoma
      Dr. Dinehart is
      Advanced
      . Learn about Squamous Cell Skin Carcinoma.
      See more Squamous Cell Skin Carcinoma experts
    • Warts
      Dr. Dinehart is
      Advanced
      . Learn about Warts.
      See more Warts experts
    • Experienced
    • Atopic Dermatitis
      Dr. Dinehart is
      Experienced
      . Learn about Atopic Dermatitis.
      See more Atopic Dermatitis experts
    • Cerebral Cavernous Malformation
      Dr. Dinehart is
      Experienced
      . Learn about Cerebral Cavernous Malformation.
      See more Cerebral Cavernous Malformation experts
    • Cherry Angioma
      Dr. Dinehart is
      Experienced
      . Learn about Cherry Angioma.
      See more Cherry Angioma experts
    • Contact Dermatitis
      Dr. Dinehart is
      Experienced
      . Learn about Contact Dermatitis.
      See more Contact Dermatitis experts
    • Eosinophilic Pustular Folliculitis
      Dr. Dinehart is
      Experienced
      . Learn about Eosinophilic Pustular Folliculitis.
      See more Eosinophilic Pustular Folliculitis experts
    • Epidermoid Cyst
      Dr. Dinehart is
      Experienced
      . Learn about Epidermoid Cyst.
      See more Epidermoid Cyst experts
    View All 26 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.